Earnings: Facebook and Merck Scheduled to Open Their Books

By: via Benzinga
Facebook (NASDAQ: FB) has managed to turn in some solid revenue gains in the last four reporting periods, as its ad revenues have ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.